Community/Retail

This article discusses seven pieces of information pharmacists should know about praxbind, the newest antidote for dabigatran approved by the FDA

The FDA is encouraging the development of new abuse-deterrent technologies to combat opioid abuse.

DNA4Life has launched a new test for patients who want to know how their bodies will respond to some of the most commonly prescribed therapeutic medications.

A pharmacist accused of injecting his wife with a medication she did not need is no longer facing charges.

With the industry's greater focus for pharmacies on clinical performance and patient outcomes, Health Mart is hosting its third series of Town Hall events.

How should pharmacists react when the Drug Enforcement Administration arrives at their pharmacy, and how can pharmacists protect themselves during a DEA investigation?

New Jersey has enacted a law to stop the sale of OTC products containing dextromethorphan (DXM) to children under 18 without a prescription.

I hate seeing summer end, but a certain distraction takes me right to the middle of February without even missing it.

Price Chopper is selling plush primates and fundraising through a month-long pin-up campaign to raise money for St. Jude Children's Research Hospital.

Pharmacy Week is a time to celebrate one of the best professions in health care.

You don't have to be an expert in automation to know that technology is catching up with pharmacy.

Medline Industries is voluntarily recalling 1 lot of acetaminophen tablets.

A recent high-profile case of a celebrity allegedly indulging in "Herbal Viagra" and cocaine highlights an overlooked problem.

Ronna B. Hauser, PharmD, vice president of pharmacy affairs for the National Community Pharmacists Association (NCPA), discusses what pharmacists need to know about the memorandum of understanding regarding the interstate shipment of compounds.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, discusses the nuances between a pharmacist's method of intervention versus the practices of other health providers.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, forecasts several different innovative solutions that are poised to drive better medication adherence over the next 2-3 years.

Complementary and alternative medicine use isn't uncommon among seniors, but it can predispose them to polypharmacy.

If all individuals with diabetic retinopathy were treated in a timely manner, the incidence of blindness from diabetes could be decreased by 90%.

Rural and cancer hospitals will no longer have access to 340B discount pricing for orphan drug purchases.

The FDA today has granted accelerated approval to Boehringer Ingelheim's intravenous solution idarucizumab (Praxbind) for the rapid reversal of Pradaxa.

ASHP announced today that it is extremely disappointed in the recent court decision by the U.S District Court for the District of Columbia that will exclude all drugs with an "orphan" designation from the 340B Drug Pricing Program for rural and cancer hospitals.

Andi Lane Clark, PharmD, Director of Clinical Field Services at Rite Aid, discusses how provider status would allow pharmacists to optimize their time and better support medication adherence for patients.

Daiichi Sankyo will reorganize its US Commercial organization as it begins to transition from a maturing primary care product portfolio to a differentiated specialty portfolio.

Synjardy, a type 2 diabetes treatment, is now available by prescription in US pharmacies.

The FDA has launched its "Fresh Empire" national public education campaign in an effort to prevent and reduce tobacco use among multicultural youth.

This weekly video program highlights the latest in pharmacy news, product news, and more.

Black children with severe pain are less likely to receive opioids in emergency rooms than white children.

With OTC remedies for colds crowding self-help shelves, experts are divided on the merits of single-symptom treatment over multi-symptom therapy.

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some of the DEA's requirements for handling controlled substances.

In recognition of American Pharmacists Month, Mel Seabright, PharmD, MBA, shares how he became a pharmacist.